B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients

BACKGROUND: Vaccination is considered as most efficient strategy in controlling SARS-CoV-2 pandemic spread. Nevertheless, patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX) are at increased risk to fail humoral and cellular responses upon vaccination. The ability to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefanski, Ana-Luisa, Rincon-Arevalo, Hector, Schrezenmeier, Eva, Karberg, Kirsten, Szelinski, Franziska, Ritter, Jacob, Chen, Yidan, Jahrsdörfer, Bernd, Ludwig, Carolin, Schrezenmeier, Hubert, Lino, Andreia C., Dörner, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063458/
https://www.ncbi.nlm.nih.gov/pubmed/35514962
http://dx.doi.org/10.3389/fimmu.2022.822885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063458/
https://www.ncbi.nlm.nih.gov/pubmed/35514962
http://dx.doi.org/10.3389/fimmu.2022.822885

Ejemplares similares